AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9405910
Drug: GLP-1 tablet
RxNorm normalized name: Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 tablet
Trial: 31526218
Drug: Heat-stable rotavirus
RxNorm normalized name: (9-L-TYROSINE)HEAT-STABLE ENTEROTOXIN (ESCHERICHIA COLI)-(6-19)-PEPTIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat-stable rotavirus vaccine (HSRV)
Trial: 25056361
Drug: Shanchol vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shanchol vaccine
Trial: 1599636
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg felodipine
Trial: 23817921
Drug: Myelin peptide
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myelin peptide skin patch (1 mg)
Trial: 8683863
Drug: Interleukin-3 (IL-3)
RxNorm normalized name: interleukin-3
DrugBank: Muplestim (DB12431)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interleukin-3 (IL-3) therapy, daily subcutaneous doses of 2.5, 5.0 or 7.5 micrograms/kg for 7 or 14 days
Trial: 4013351
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg spironolactone + 5 mg butizide (SB)
Trial: 4013351
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg spironolactone + 20 mg furosemide (SF)
Trial: 29546527
Drug: 10 hours
RxNorm normalized name: buprenorphine
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: 10 hours bed rest after intrathecal chemotherapy
Trial: 3289830
Drug: isoxicam 200
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: isoxicam 200 mg
Trial: 12533165
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride solution (control)
Trial: 31952923
Drug: rVSVN4CT1-EBOVGP1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rVSVN4CT1-EBOVGP1 vaccine (2·5×10^4 PFU, 2×10^5 PFU, 1·8×10^6 PFU)
Trial: 31952923
Drug: rVSVN4CT1-EBOVGP1 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rVSVN4CT1-EBOVGP1 vaccine
Trial: 9641566
Drug: Subcutaneous immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunotherapy (SIT)
Trial: 11240959
Drug: Atopy patch
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atopy patch test (APT)
Trial: 24427279
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day DHA from 16 wk gestation to delivery
Trial: 19006471
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg rosuvastatin alone
Trial: 12414411
Drug: Topical ofloxacin
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical ofloxacin 0.3% applied 1 hour before surgery
Trial: 9737101
Drug: TTS fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TTS fentanyl (25, 50, 75, or 100 micrograms/hr) administered as a transdermal patch every 3 days
Trial: 8287749
Drug: Oral mesalazine
RxNorm normalized name: mesalamine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mesalazine (0.5 g three times/day)
Trial: 1464341
Drug: Captopril low
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Captopril low dose group (incremental doses of 6.25, 12.5, and 25.0 mg)
Trial: 4054194
Drug: Atenolol 100
RxNorm normalized name: atenolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 100 mg once daily
Trial: 3897071
Drug: Prazosin 2
RxNorm normalized name: prazosin 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin 2 mg twice a day
Trial: 8796773
Drug: Prophylactic intravenous
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic intravenous bolus of ephedrine (10 mg)
Trial: 23715924
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (300 mg magnesium as citrate)
Trial: 27444761
Drug: Betamethasone gel
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone gel
Trial: 9706829
Drug: ACE-inhibitors started
RxNorm normalized name: venetoclax
DrugBank: Venetoclax (DB11581)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: ACE-inhibitors started within the first day after acute myocardial infarction and continued for 4 to 6 weeks.
Trial: 9706829
Drug: ACE-inhibitors for
RxNorm normalized name: Gastric inhibitory polypeptide
DrugBank: Gastric inhibitory polypeptide (DB15217)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-inhibitors for patients with LVD.
Trial: 9706829
Drug: ACE-inhibitors for
RxNorm normalized name: Gastric inhibitory polypeptide
DrugBank: Gastric inhibitory polypeptide (DB15217)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE-inhibitors for patients without evidence of LVD.
Trial: 2654350
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (free alpha-tocopherol) administered parenterally and later orally at pharmacologic serum levels (5 mg/dl)
Trial: 2654350
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (free alpha-tocopherol) administered for greater than or equal to 8 days
Trial: 889333
Drug: Salicylic acid
RxNorm normalized name: Salicylic Acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salicylic acid 2% cream
Trial: 30572894
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g placebo
Trial: 17227802
Drug: Oral alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alendronate 70 mg/wk
Trial: 3819391
Drug: Felodipine 5
RxNorm normalized name: felodipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5 mg t.i.d. for 3 days
Trial: 10695793
Drug: Albendazole 400
RxNorm normalized name: albendazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole 400 mg once a day for 3 days
Trial: 19846008
Drug: Low-tidal-volume group
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-tidal-volume group (tidal volume no more than 6 ml/kg of predicted body weight)
Trial: 17241418
Drug: Topical botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical botulinum toxin type A (BTX‐A) 200 U applied to one axilla
Trial: 10853619
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 10 mg/kg (as caffeine base) administered intravenously, followed by 2.5 mg/kg/day orally or intravenously, for up to 10 days.
Trial: 23018283
Drug: Clozapine suspension
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine suspension (50 mg/mL)
Trial: 22117974
Drug: Molecular target
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Molecular target therapy gefitinib (group I)
Trial: 6741668
Drug: High maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High maintenance doses of methadone (Group 1) for a 14-week period
Trial: 12213433
Drug: Carnitine treatment
RxNorm normalized name: carnitine
DrugBank: Levocarnitine (DB00583)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carnitine treatment
Trial: 11561033
Drug: Respiratory therapy
RxNorm normalized name: respiratory therapy supplies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory therapy (RET)
Trial: 3542496
Drug: Colchicine therapy
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colchicine therapy (4 X 0.25 mg/d for five days a week)
Trial: 22234594
Drug: Virtual reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality (VR) training simulator for hysteroscopic placement of tubal sterilization implants
Trial: 796755
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg chlorpromazine‐‐250 mg alpha‐methyldopa/day
Trial: 3315283
Drug: Intramuscular methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular methotrexate
Trial: 963493
Drug: Antitrichomonal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antitrichomonal therapy
Trial: 29226816
Drug: Intravenous furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous furosemide (IV), mean dose: 123 ± 47 mg
Trial: 29226816
Drug: Intravenous furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous furosemide (IV)
Trial: 22958024
Drug: Extra-protein group
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-protein group (4.8 g kg(‐1) per day)
Trial: 17436778
Drug: Creatine (Cr)
DrugBank: Creatine (DB00148)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Creatine (Cr) 20 g/day for 7 days
Trial: 19237980
Drug: CSL 10
RxNorm normalized name: CSL-689
DrugBank: CSL-689 (DB17726)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CSL 10 ml/kg
Trial: 7867678
Drug: mizolastine 40
RxNorm normalized name: mizolastine
DrugBank: Mizolastine (DB12523)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mizolastine 40 mg
Trial: 14707789
Drug: Intensification of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensification of standard antiretroviral therapy with abacavir, with or without efavirenz.
Trial: 30771686
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (4.4 g/d)
Trial: 8929936
Drug: Social model
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social model residential program providing integrated mental health and substance abuse treatment
Trial: 26286532
Drug: Post-treatment predictor
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Post-treatment predictor models
Trial: 21127322
Drug: Intracoronary autologous
RxNorm normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary autologous bone marrow cell infusion (BMC)
Trial: 26763495
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy
Trial: 19454032
Drug: Haloperidol 0.5
RxNorm normalized name: haloperidol 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol 0.5 to 2 mg/hour (with or without loading doses of 2.5 mg)
Trial: 30987663
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (NaHCO3) supplementation (0.2 g/kg body mass)
Trial: 10594487
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg itraconazole
Trial: 3721047
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (i.v. infusion of Hydralazine and MgSO4)
Trial: 10582134
Drug: HD-EPI 120
RxNorm normalized name: 8-epi-cyanocobalamin
DrugBank: 8-epi-Cyanocobalamin (DB14092)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD-EPI 120 mg/m2 + CP 60 mg/m2
Trial: 15295955
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg with hydrocodone 5 mg
Trial: 18094224
Drug: Ibuprofen 400
RxNorm normalized name: ibuprofen 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 400 mg alone
Trial: 12132977
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (150 mg, twice daily for 7 weeks)
Trial: 28416344
Drug: Sunbed intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sunbed intervention (twice weekly exposure for 12 weeks)
Trial: 25087839
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg BIW for < 12 weeks (or ETN 25 mg BIW for an extra 12 weeks until PGA < 2 was achieved) during Cycle 1
Trial: 9040549
Drug: Formula 8
RxNorm normalized name: Joint Formula 88 Max Plus
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula 8 (iron approximately 143 mumol/L or 8 mg/L)
Trial: 29560939
Drug: Tenoxicam 20
RxNorm normalized name: tenoxicam 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam 20 mg orally per day
Trial: 24809838
Drug: Low-dose ketamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ketamine infusion
Trial: 21914315
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg, 3 times a day
Trial: 25926408
Drug: Coarse+LBG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coarse+LBG treatment (larger, 6-μm mean droplet size with 0.5% locust bean gum)
Trial: 21343383
Drug: THC (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC (2.5 mg, Marinol(®), twice daily for 18 days)
Trial: 18781875
Drug: Control vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control vaccine (Meningococcal conjugate vaccine against serogroup C)
Trial: 25424793
Drug: 7-valent pneumococcal
RxNorm normalized name: Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-valent pneumococcal conjugate vaccine (PCV7)
Trial: 16359793
Drug: Gabapentin-morphine combination
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin-morphine combination
Trial: 12666979
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose doxycycline (20 mg, b.i.d.)
Trial: 16044962
Drug: MMC +
RxNorm normalized name: MMC
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMC + HCFU (300 mg/day orally for one year)
Trial: 3551972
Drug: TAD consolidation
RxNorm normalized name: BAG,LEG LARGE CONSOLIDATED #0932
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAD consolidation with monthly maintenance chemotherapy
Trial: 26818127
Drug: Tripterygium glycoside
RxNorm normalized name: anthraquinone glycoside
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tripterygium glycoside (TPT), 2 pills three times daily for 2 months
Trial: 30870291
Drug: Intravenous furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous furosemide 10 mg
Trial: 1565347
Drug: 5-mg PGE2
RxNorm normalized name: dinoprostone
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-mg PGE2 gel
Trial: 1776748
Drug: HP 128
RxNorm normalized name: HP 502
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HP 128 (adrenergic/cholinergic agent) administered for 10 days
Trial: 27265548
Drug: First-generation antipsychotics
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotics (FGAs) - haloperidol (3-6 mg) or flupentixol (6-12 mg)
Trial: 19916263
Drug: 595 nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 595 nm pulsed dye laser (PDL) with compression handpiece (CHP), 6 J/cm2, 6 msec pulse duration, three monthly treatments
Trial: 15591642
Drug: Ketoprofen administered
RxNorm normalized name: Ketoprofen
DrugBank: Ketoprofen (DB01009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoprofen administered one hour before incision (PRE group)
Trial: 25872773
Drug: Cascade intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cascade intervention (online cognitive-behavioural therapy)
Trial: 9109825
Drug: NaF rinse
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NaF rinse (12 mmol/L, 228 ppm)
Trial: 9314342
Drug: House dust
RxNorm normalized name: House dust
DrugBank: House dust (DB10345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: House dust mite avoidance treatment
Trial: 10996576
Drug: Salmon calcitonin
RxNorm normalized name: Salmon calcitonin
DrugBank: Salmon calcitonin (DB00017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmon calcitonin nasal spray 200 IU
Trial: 22412114
Drug: Antihypertensive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive therapy
Trial: 8738770
Drug: Caffeine citrate
RxNorm normalized name: Caffeine Citrate
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine citrate 3 mg/kg, 15 mg/kg, or 30 mg/kg administered once daily for 7 days
Trial: 15898977
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with depigmented glutaraldehyde-polymerized extracts (Group-A)
Trial: 22968811
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of ketoconazole after St John's wort induction
Trial: 17617285
Drug: Guanfacine extended-release
RxNorm normalized name: Guanfacine Extended-Release Tablets
DrugBank: Guanfacine (DB01018)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Guanfacine extended-release (GXR) 4 mg
Trial: 1827125
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day spironolactone
Trial: 30952488
Drug: Hydroxyurea 20
RxNorm normalized name: hydroxyurea 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea 20 mg/kg/day
Trial: 17390549
Drug: Quinapril 10
RxNorm normalized name: quinapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril 10 mg
Trial: 17967675
Drug: parecoxib 20
RxNorm normalized name: parecoxib 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: parecoxib 20 mg (IV) twice daily (n = 211)
Trial: 7931615
Drug: Reduced-dose craniospinal
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-dose craniospinal radiotherapy (2400 cGy).
Trial: 16492212
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine + insulin lispro
Trial: 12932068
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia (TIVA) (Group TIVA)
Trial: 23716037
Drug: Odanacatib 25
RxNorm normalized name: Odanacatib
DrugBank: Odanacatib (DB06670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odanacatib 25 mg
Trial: 19874198
Drug: Odanacatib 50
RxNorm normalized name: Odanacatib
DrugBank: Odanacatib (DB06670)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Odanacatib 50 mg
Trial: 23019990
Drug: Positive barium
RxNorm normalized name: barium
DrugBank: Barium (DB12481)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive barium sulphate suspension (900 ml, 2.1% w/v)
Trial: 30605396
Drug: Heat therapy
RxNorm normalized name: CVS Neck Arm & Leg Heat Therapy Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heat therapy (HT)
Trial: 16424795
Drug: Lercanidipine 20
RxNorm normalized name: lercanidipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine 20 mg/d for 15 days
Trial: 10702763
Drug: Sibutramine 10
RxNorm normalized name: sibutramine 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sibutramine 10 mg per os, once a day
Trial: 22797645
Drug: 420-mg silymarin
RxNorm normalized name: silymarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 420-mg silymarin
Trial: 1672843
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg slow-release isosorbide-5-mononitrate (IS-5-MN) after a 7-day therapy